R. Ciftci Et Al. , "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , vol.49, Amsterdam, Netherlands, 2013
Ciftci, R. Et Al. 2013. Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma. European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , (Amsterdam, Netherlands).
Ciftci, R., Karabulut, S., Tastekin, D., Sen, F., Kilic, L., Yildiz, I., ... Keskin, S.(2013). Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma . European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands
Ciftci, R. Et Al. "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma," European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 2013
Ciftci, R. Et Al. "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands, 2013
Ciftci, R. Et Al. (2013) . "Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma." European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO , Amsterdam, Netherlands.
@conferencepaper{conferencepaper, author={R. Ciftci Et Al. }, title={Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma}, congress name={European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO}, city={Amsterdam}, country={Netherlands}, year={2013}}